Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dual chemo combo with great results

<< Previous

Bullboard Posts

Next >>

Post by N0taP00pon Feb 16, 2023 7:18pm

494 Views

Post# 35291096

Dual chemo combo with great results

Very interesting study (see limitations in article) with great results from treating BCG resistant NMIBC patients with a combo-chemo treatment. More than 80% of patients showed no recurrence after 2 years. Minor side effects too. Requires monthly treatment though. But still a great alternative to removing a bladder.

https://www.cancer.gov/news-events/cancer-currents-blog/2022/bladder-cancer-chemo-effective-alternative

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)